Credo Technology Group Holding Ltd enters the week with a striking reversal from last week's setup: shorts that rebuilt aggressively after the fiscal Q4 print are now cutting back, even as analysts have spent the past fortnight scrambling to lift targets on a stock that has already moved well past many of them.
The positioning shift is the clearest change from last week's note. Short interest has fallen 8.6% over the week to 6.3% of the free float — down from the 6.8% level flagged just days ago — meaning the deliberate rebuild that followed earnings is already partially unwinding. The borrow market offers no friction either way: availability sits at a vast 1,971%, meaning there are nearly 20 shares available to lend for every one currently borrowed, and cost to borrow has dropped 30% on the week to just 0.39%. Shorts can exit or re-enter without any squeeze pressure. Options positioning has tilted more bullish. The put/call ratio has fallen to 0.79, about one standard deviation below its 20-day average of 0.86 — close to its 52-week low of 0.68 — reflecting a distinct preference for call exposure as the stock pushed above $250. Overall, the lending and options picture is asymmetric: the bears are backing off, and the options market is leaning toward the upside.
The Street validated the move with force after the earnings print. Nine analysts raised targets on June 2 alone, maintaining buy-equivalent ratings across the board. JP Morgan lifted its target to $250, BofA Securities moved to $252, Jefferies went to $270, Needham to $275, Mizuho to $290, and Roth Capital to $300. The mean target now sits at $256 — essentially in line with the current price of $250.81, which tells the story neatly: the stock has closed the gap on analyst expectations in under two weeks. The bull case centres on optical portfolio expansion and the Dust Photonics acquisition opening a new addressable market. Bears counter that the near-term revenue mix remains dependent on copper AEC products, margins face integration costs, and forward earnings multiples — PE near 35x trailing, EV/EBITDA around 28x — leave the stock with limited room for error. EPS momentum, however, is exceptional: the 90-day EPS revision score ranks in the 96th percentile, signalling that estimate upgrades are still outpacing the broader market.
Founder and CTO Lawrence Cheng sold roughly $4.8 million of stock on June 11 across multiple tranches, with prices ranging from $249 to $267. The sales follow a 90-day net insider position that remains modestly positive at around $13.2 million net sold — typical for a founder managing liquidity into a strong run. BlackRock raised its stake to 10.7% in its most recent filing, and Point72 added nearly 1.9 million shares in Q1, suggesting the institutional bid behind the rally carries credibility beyond passive flows. Wellington added 1.35 million shares through April. The founder selling is notable on timing but not on size — it reads as plan-driven rather than a conviction call on the stock.
The peer tape adds useful context. ICHR jumped 38% on the week and COHU gained 23%, suggesting a broad semiconductor equipment bid this week. ALAB climbed nearly 16%. CRDO's own 21% weekly gain — with a 5% pullback on Friday alone — places it squarely in the middle of the peer pack rather than at the front. The Friday drop, on a day when most peers held flat or gained, hints at some profit-taking at resistance as the stock approaches the cluster of analyst targets.
With the next earnings event not until September 1, the coming weeks reduce to a simpler question: whether momentum buyers stay interested in a stock that has now fully priced in the post-earnings analyst upgrade cycle, or whether the partial short rebuild seen in late May reasserts itself now that the easy catalyst is in the rearview mirror.
See the live data behind this article on ORTEX.
Open CRDO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
